Last reviewed · How we verify
NCT06638372
Caffeinated Chewing Gum on Special Forces Performance
NA trial testing caffeine in Caffeine in 16 participants. Completed in 30 May 2025.
6 October 2024
Quick facts
| Lead sponsor | National Taiwan Sport University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 16 |
| Start date | 5 October 2024 |
| Primary completion | 6 October 2024 |
| Estimated completion | 30 May 2025 |
| Sites | 1 location across Taiwan |
Drugs / interventions tested
- caffeine (caffeine) — full drug profile →
Conditions studied
Sponsor
National Taiwan Sport University
Who can join
Adults 20 to 40, male only, with Caffeine or Placebo. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this project is to investigate the effects of caffeine chewing gum on the cognitive functions and special operations capabilities of special forces.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Caffeinated chewing gum improves military performances in special forces soldiers.
Shiu YJ, Chen CH, Lin HY, Yang CC, et al · · 2026 · PMID 42142184 · DOI 10.1007/s00421-026-06247-0
Verify or expand the search:
- PubMed search for NCT06638372
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of caffeine
Trials testing the same drug.
- NCT07412951 — Effects of Caffeine and Shot Put Performance · NA · active not recruiting
- NCT06758336 — Caffeinated Chewing Gum & Wrestling Performance · NA · completed
- NCT06430996 — Caffeinated Chewing Gum on 400-meter Performance · NA · completed
- NCT06431035 — Caffeine & Bodybuilding Dehydration Ability · NA · completed
- NCT05806476 — Caffeine, DNA and Cognition · NA · unknown
Other recruiting trials for Caffeine
Currently open trials in the same condition.
- NCT07469852 — Effects of Caffeine Ingestion on Morning Cognitive and 4-km Time Trial Performance in Males · Phase 1, PHASE2 · active not recruiting
- NCT07404254 — Effects of Variations in Caffeinated Beverages on Well-being · NA · recruiting
- NCT06763172 — Effects of Caffeine on Reinforcement Learning in Healthy Adults Using PET/MRI · Phase 4 · recruiting
- NCT05325502 — Does Caffeine Facilitate Human Reward Learning Behaviors? · NA · active not recruiting
- NCT05454332 — The Caffeine Therapy in the Fetal to Neonatal Transition · Phase 4 · recruiting
Other National Taiwan Sport University trials
Trials by the same sponsor.
- NCT07412951 — Effects of Caffeine and Shot Put Performance · NA · active not recruiting
- NCT07175766 — Dachundou No Sugar Added Soymilk for Lipid Modulation · NA · completed
- NCT06902662 — Sanghuangporus Sanghuang Supplementation to Improve Anti-Fatigue Performance in Healthy Adults · NA · completed
- NCT06670742 — Gut-muscle Axis: Exploring the Gut Microbiota Influences Host Energy Sources and Exercise Performance · NA · not yet recruiting
- NCT06893549 — Effect of Lactobacillus Plantarum GKK1 Supplementation on Anti-fatigue Health Effects · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06638372 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by National Taiwan Sport University
- Last refreshed: 26 June 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06638372.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing